This research compound was first described by Hoffman-La Roche in 2009. It’s amongst various benzodiazepines within the imidazobenzodiazepine subgroup imagined to deliver nootropic Added benefits.There’s very little details about this Russian-created benzodiazepine, however it’s occasionally noticed on designer drug marketplaces under the nam… Read More